ReviewCardiac failure review2026
When the Heart Meets the Pillow: Building Cross-disciplinary Solutions for Sleep-disordered Breathing.
Review in Cardiac failure review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The interplay between sleep-disordered breathing (SDB) and cardiovascular disease, particularly arrhythmias and heart failure, is complex and bidirectional. This article examines the impact of SDB in cardiovascular disease and heart failure. It is proposed that teams interested in improving SDB diagnosis and management take ACTION (assess for risk factors/screening in each visit; collaborate with sleep colleagues for referrals/visits; test for SDB with home sleep apnoea test, polysomnography; intervene with SDB-specific treatment (oral devices, continuous positive airway pressure, bilevel positive airway pressure, phrenic nerve and hypoglossal nerve stimulators) including risk factor modification (weight reduction, alcohol abstinence); continue ongoing assessment by cardiology and sleep teams for feedback about treatment; creating niche programmes for AF, heart failure and weight loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.